That's what I meant... shorts covered early jacking up the price early, then a sell off of profit takers and RE- shorters... just speculating.
Everything I've read over the last few hours, there seems to be a consensus that a RS is a MUST for to buy more time for trials and FDA approvals. Doesn't seem good for a long holder in the short term.